We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment and Response |

Ascorbic Acid Supplements and Kidney Stone Risk—Reply

Hans-Göran Tiselius, MD1; Agneta Åkesson, PhD2; Laura D. K. Thomas, MSc2
[+] Author Affiliations
1Department of Clinical Science, Intervention, and Technology, CLINTEC, Karolinska Institutet, Stockholm, Sweden
2Institute of Environmental Medicine, Division of Nutritional Epidemiology, Karolinska Institutet
JAMA Intern Med. 2013;173(14):1384a. doi:10.1001/jamainternmed.2013.7699.
Text Size: A A A
Published online


In Reply Dr Hoffer reasons that the investigation of nonspecific abdominal or flank pain may result in the diagnosis of nonsymptomatic kidney stones and that such diagnoses are more likely among ascorbic acid supplement users, leading to an overestimation of the risk. We believe it is highly improbable that those presenting with such symptoms would be more likely to be examined with respect to stone disease if they have a history of ascorbic acid supplement use. First, for this to be the case, the patient would have to provide information on their supplement use either after being asked by their physician or without having been prompted to do so. Second, the physician would have to consider use of ascorbic acid supplements, by the patient, sufficient to warrant the prioritization of diagnostic tests for kidney stones over those of other potential causes.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





July 22, 2013
L. John Hoffer, MD, PhD
1Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
JAMA Intern Med. 2013;173(14):1384. doi:10.1001/jamainternmed.2013.7731.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Related Collections